Robert Lookstein, MD, FSIR, has been serving as the chief of interventional radiology at Mount Sinai for more than a decade and has worked in numerous roles with SIR for 20 years.
This new information on the pathogenesis of both conditions could be useful for the development of interventions targeted at slowing cognitive decline.
The new Department of Imaging Sciences will be spearheaded by Elizabeth M.C. Hillman, PhD, a physicist, biomedical engineer, neuroscience researcher and inventor.
Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.
The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.